Dec 15, 2021 PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights
Dec 8, 2021 PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay
Nov 30, 2021 PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study
Nov 12, 2021 PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation
Sep 21, 2021 PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests
Sep 8, 2021 PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Aug 31, 2021 PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study
